Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 433,167,328
  • Shares Outstanding, K 2,633,396
  • Annual Sales, $ 82,584 M
  • Annual Income, $ 14,714 M
  • 60-Month Beta 0.71
  • Price/Sales 5.27
  • Price/Cash Flow 15.19
  • Price/Book 6.60
Trade JNJ with:

Options Overview

Details
  • Implied Volatility 14.39%
  • Historical Volatility 11.87%
  • IV Percentile 3%
  • IV Rank 4.04%
  • IV High 33.44% on 10/30/20
  • IV Low 13.59% on 06/10/21
  • Put/Call Vol Ratio 0.41
  • Today's Volume 16,111
  • Volume Avg (30-Day) 30,106
  • Put/Call OI Ratio 0.81
  • Today's Open Interest 456,409
  • Open Int (30-Day) 424,660

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 2.28
  • Number of Estimates 7
  • High Estimate 2.43
  • Low Estimate 2.17
  • Prior Year 1.67
  • Growth Rate Est. (year over year) +36.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
162.07 +1.46%
on 06/08/21
172.74 -4.81%
on 05/21/21
-5.79 (-3.40%)
since 05/14/21
3-Month
156.53 +5.05%
on 04/13/21
172.74 -4.81%
on 05/21/21
+3.06 (+1.90%)
since 03/16/21
52-Week
133.65 +23.03%
on 10/30/20
173.65 -5.31%
on 01/26/21
+19.97 (+13.82%)
since 06/16/20

Most Recent Stories

More News
Thailand sets mid-October to reopen to vaccinated visitors

BANGKOK (AP) — Thailand plans to fully reopen to vaccinated foreign visitors by mid-October as the government seeks to restart the crucial coronavirus-devastated tourism industry, the prime minister...

JNJ : 164.43 (-0.04%)
The Latest: COVID-19 cases rise in Missouri tourist areas

O’FALLON, Mo. — A swath of southern Missouri is seeing a big rise in coronavirus cases and hospitalizations at just the wrong time — as tourists eager to get out after being cooped up for a year...

JNJ : 164.43 (-0.04%)
DIS : 174.66 (-0.68%)
RCL : 88.52 (+1.83%)
The Latest: Disney plans to restart fireworks shows at parks

ORLANDO, Fla. — Disney plans to restart fireworks shows at its theme parks in Florida and California in the latest move by the company to ease up on pandemic restrictions implemented last year.

PFE : 39.30 (-0.73%)
TM : 183.84 (+0.76%)
DIS : 174.66 (-0.68%)
JNJ : 164.43 (-0.04%)
Novavax's (NVAX) COVID-19 Vaccine Shows 90% Efficacy in US Study

Novavax's (NVAX) COVID-19 vaccine candidate, NVX-CoV2373, shows an overall efficacy of 90% in the phase III PREVENT-19 study in the United States and Mexico.

JNJ : 164.43 (-0.04%)
MRNA : 197.84 (-1.86%)
NVAX : 176.24 (-5.79%)
BNTX : 203.85 (-6.56%)
Should Oshares U.S. Quality Dividend ETF (OUSA) Be on Your Investing Radar?

Style Box ETF report for OUSA

OUSA : 41.51 (-0.82%)
MSFT : 257.38 (-0.38%)
JNJ : 164.43 (-0.04%)
HD : 302.78 (-1.20%)
VTV : 138.88 (-0.69%)
IWD : 159.24 (-0.65%)
The Latest: Vaccinated Hawaiian positive for delta variant

HONOLULU -- Hawaii says a vaccinated Oahu resident who traveled to Nevada last month has tested positive for the delta variant of COVID-19.

PFE : 39.30 (-0.73%)
JNJ : 164.43 (-0.04%)
Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know

Johnson & Johnson (JNJ) closed the most recent trading day at $165.37, moving +0.25% from the previous trading session.

JNJ : 164.43 (-0.04%)
Novavax: Large study finds COVID-19 shot about 90% effective

Vaccine maker Novavax said Monday its COVID-19 shot was highly effective against the disease and also protected against variants in a large study in the U.S. and Mexico, potentially offering the world...

JNJ : 164.43 (-0.04%)
J&J (JNJ) Gets FDA Nod for 10M COVID Vaccines, Discards Many

J&J (JNJ) gets authorization for two batches of COVID-19 vaccine doses manufactured at Baltimore facility but the FDA discards several others. Europe and Canada stop the rollout of some batches of the...

AZN : 58.41 (-0.73%)
JNJ : 164.43 (-0.04%)
PFE : 39.30 (-0.73%)
EBS : 61.96 (+0.63%)
AstraZeneca (AZN) COVID-19 Jab's New Side Effect Stated by EMA

The PRAC of the European Medicines Agency (EMA) has advised against giving AstraZeneca's (AZN) Vaxzevria COVID-19 vaccine to people with a history of capillary leak syndrome, a rare blood disorder.

AZN : 58.41 (-0.73%)
JNJ : 164.43 (-0.04%)
PFE : 39.30 (-0.73%)
MRNA : 197.84 (-1.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Key Turning Points

3rd Resistance Point 167.90
2nd Resistance Point 166.82
1st Resistance Point 165.63
Last Price 164.43
1st Support Level 163.36
2nd Support Level 162.28
3rd Support Level 161.09

See More

52-Week High 173.65
Last Price 164.43
Fibonacci 61.8% 158.37
Fibonacci 50% 153.65
Fibonacci 38.2% 148.93
52-Week Low 133.65

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar